SurgOnc Today®

In this episode of SurgOnc Today, Dr. Zhi Ven Fong, of the HPB Disease Site Work Group interviews Dr. Yorick L. van de Pavert about the ENDURO Trial's (surgical vs endoscopic gastrojejunostomy bypass) design, implementation, and primary and secondary endpoints. If you did not check out part 1, please be sure to visit SurgOnc Academy for the full series: https://learn.surgonc.org/courses/112569

In this series "evidence today and tomorrow", the HPB disease site working group of the SSO explores current gaps in HPB surgical oncology, highlighting existing evidence and ongoing work aimed at filling those gaps. In this episode, Drs. Julie Hallet and Patricio Polanco, chair and vice-chair of the HPB disease site working group are joined by Drs. Ajay Maker, Rebecca Snyder, and Giovanni Marchegiani to review evidence in the management of pancreatic cystic neoplasms.

In this episode of SurgOnc Today, we discuss the recently updated ASCO guidelines for axillary staging with sentinel lymph node biopsy in breast cancer, as well as considerations for their application in a multidisciplinary setting. This episode is moderated by Dr. Ashley Woodfin from the University of Wisconsin, who is joined by Dr. Clara Park from Brigham and Women's Hospital and Dr. Andrea Abbott from Medical University of South Carolina for a in-depth discussion regarding the guidelines implementation and important considerations.

In this episode of Outside the OR, we explore how collaboration between the Society of Surgical Oncology (SSO) and the American College of Surgeons Cancer Surgery Standards Program (ACS CSSP) is helping raise the bar for cancer care nationwide. Joined by Dr. Matthew H.G. Katz and Dr. Tina J. Hieken, we discuss how shared standards, multidisciplinary alignment, and surgeon leadership translate into better support for surgeons, and better outcomes for patients. Tune in for a thoughtful conversation on why collaboration matters and how collective efforts are shaping the future of cancer surgery.

In this new episode of Speaking of SurgOnc, Dr. Rick Greene and Dr. Shayna Showalter discuss recently updated considerations by the SSO Breast Task Force regarding bilateral and contralateral risk-reducing mastectomy, highlighting important considerations for clinical practice, as reported in the editorial, "Highlights and Perspectives from The Society of Surgical Oncology's Statements on Bilateral and Contralateral Risk-Reducing Mastectomy."